Product
Help
Pricing
About
Jobs
Log in
Get started
Work
Add to collection
Ranibizumab: new drug. Macular degeneration: second-line use due to risks.
PubMed
Details
Locations
Year:
2008
Type:
article
Source:
PubMed
Language:
English
Topic:
Retinal Diseases and Treatments
Subfield:
Ophthalmology
Field:
Medicine
Domain:
Health Sciences
Keywords:
ranibizumab,
neovascular age-related macular degeneration,
VEGF inhibitors,
verteporfin,
photodynamic therapy,
pegaptanib,
intravitreal injection,
visual acuity outcomes,
stroke risk,
adverse effects,
anti-VEGF therapy
show all 11
SDG:
Good health and well-being
Open Access status:
closed
OpenAlex ID:
W4300951452
FWCI:
0.308
Cites:
Cited by:
1
Related to:
9